CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 113 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q2 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,470,337 | -25.3% | 158,971 | +8.8% | 0.00% | -33.3% |
| Q2 2023 | $4,644,392 | +49.5% | 146,096 | +14.7% | 0.00% | +50.0% |
| Q1 2023 | $3,107,554 | -19.4% | 127,411 | +4.6% | 0.00% | 0.0% |
| Q4 2022 | $3,853,526 | +16.7% | 121,839 | +3.1% | 0.00% | 0.0% |
| Q3 2022 | $3,301,349 | +7.4% | 118,166 | +3.4% | 0.00% | 0.0% |
| Q2 2022 | $3,074,931 | -16.9% | 114,323 | +4.5% | 0.00% | 0.0% |
| Q1 2022 | $3,699,925 | +469.2% | 109,385 | +452.8% | 0.00% | – |
| Q4 2021 | $650,000 | +9.8% | 19,789 | -1.3% | 0.00% | – |
| Q3 2021 | $592,000 | +14.5% | 20,054 | -0.6% | 0.00% | – |
| Q2 2021 | $517,000 | – | 20,177 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |